Majority of Patients Treated with Lebrikizumab Achieved Skin Clearance in Lilly's Pivotal Phase 3 Atopic Dermatitis Studies
Posted:
Millions of people with atopic dermatitis cope with both seen and unseen burdens of the disease. Discover more about important new clinical trial results and how Lilly is helping to improve care and understanding of this disease here.
NHS clinicians will be supported to use groundbreaking AI tools that bulldoze bureaucracy and take notes to free up staff time and deliver better care to patients thanks to guidance published today.
Read more here.
A new technology partnership formally announced today, could help NHS, local government, and housing organisations collaborate to create an unprecedented understanding of the risks and needs of people in their care.
Read more here.